← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2020-07-14

Drug application

FDA Application #

ANDA213374

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

DEFERASIROX ORAL

Active ingredients

DEFERASIROX

Dosage form

GRANULE

Route

ORAL

Marketing status

Prescription

Sponsor

ALKEM LABS LTD

Manufacturer

Ascend Laboratories, LLC

First approval

2020-07-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown